Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov
Condition: Acute Myocardial Infarction
Study Type: Interventional
Study Start Date: 12/09/2016
Study Completion Date: 07/17/2019
The purpose of this study is to test if LCZ696 taken twice a day, compared to Ramipril taken twice a day, is safe and effective in reducing complications following an acute myocardial infarction (post-AMI), such as death from cardiovascular (CV) causes, hospitalization for heart failure (HF), or outpatient HF.